CME Group Files Suit Against CFTC Over Kalshi's Bitcoin Perps — And the Stakes Go Far Beyond One Exchange
CME Group sued the CFTC on June 18 over Kalshi's bitcoin perpetual futures approval, arguing they're swaps under Dodd-Frank. Here's what it means for prediction market traders.

The world's largest derivatives exchange filed a federal lawsuit against its own regulator on Thursday, June 18, 2026, targeting a single product approval that CME Group CEO Terrence Duffy calls "the most dangerous regulatory misstep in modern derivatives history." The target: the CFTC's May 29 decision to allow prediction market platform Kalshi to list the first U.S.-regulated perpetual bitcoin futures contract.
But the fight is not really about Kalshi. It is about who controls the future of U.S. crypto derivatives — and whether the rules of the road are set by Congress through Dodd-Frank, or by a regulator moving at startup speed.
What Kalshi Actually Launched
On May 28, 2026, KalshiEX LLC submitted a voluntary product approval request to the CFTC under Commission Regulation 40.3 for a contract called the BTCPERP — a perpetual futures contract that references the spot price of bitcoin via the CF Benchmarks Bitcoin Real Time Index (BRTI).
The next day, May 29, the CFTC issued an Order for Approval under Section 5c(c)(4) of the Commodity Exchange Act. CFTC Press Release 9240-26 confirmed that the BTCPERP contract "complies with the Commodity Exchange Act and the Commission's regulations thereunder" and could be listed as a futures contract on a CFTC-designated contract market.
This was historic. Before May 2026, no U.S.-regulated platform had ever offered perpetual futures — contracts with no expiration date that allow traders to hold positions indefinitely, with periodic funding payments between long and short holders to anchor prices near the spot market. The product class had been a massive offshore market for years, dominated by exchanges like Binance, Bybit, and the now-CFTC-approved Deribit. American traders who wanted access either opened offshore accounts or went without.
Kalshi's BTCPERP crossed $1 billion in trading volume within days of launch — a milestone that Kalshi's original prediction market business took 40 months to reach. By early June, Bloomberg reported the product had generated $5.5 billion in volume in its first two weeks.
CFTC Chair Michael Selig, who signed the approval, called it a watershed moment. "This morning, the CFTC took historic action to permit the listing of a true bitcoin perpetual contract by a CFTC-registered exchange," he wrote in a statement on May 29. "The question was never whether crypto asset perpetual contracts would exist. The question was whether they would exist under American oversight, American standards, and American rules."
CME's Core Argument: These Are Swaps, Not Futures
CME Group has a different view.
Outgoing CEO Terrence Duffy, who announced his departure on the same day as the lawsuit, laid out CME's central argument on CNBC's Fast Money on June 17:
"Under the Dodd-Frank Act, it clearly defines what a swap is and what a future is. And when there's two parties exchanging payments to each other, that's deemed a swap."
Perpetual futures rely on a mechanism called a funding rate — periodic payments between traders that keep the contract price anchored to the spot market. Because there is no fixed settlement date, CME argues, these payment exchanges are structurally identical to what Dodd-Frank defines as a swap.
Futures contracts, by CME's reading, must have a definite delivery date and converge to a final cash price on a fixed settlement day. Perpetual contracts have neither. Under Dodd-Frank, CME argues, the CFTC cannot simply label a product a "future" because it is listed on a designated contract market — the product's actual economic mechanics control the legal classification.
If Duffy is right, the CFTC's approval order would be invalid under the Administrative Procedure Act — a significant legal theory that CME's outside counsel has reportedly been constructing for eight months.
The Benchmark License Angle
Duffy added a structural weapon to CME's legal arsenal that could have far-reaching consequences even if the swap-classification argument fails.
CME holds exclusive licensing agreements with every major benchmark provider whose indexes underpin crypto derivatives pricing. This includes index providers like CF Benchmarks, whose Bitcoin Real Time Index backs Kalshi's BTCPERP contract.
"We have an exclusive license with every single provider of the benchmarks," Duffy told CNBC. "So all of these would have to go through CME regardless of the perpetual. They would have to list them as swaps, if that's the way that it came out."
In plain terms: if a court agrees that perpetual futures are swaps, any platform offering them — Kalshi, Coinbase, Kraken, or anyone else — would need to route those products through CME's own infrastructure to use those benchmark indices, regardless of which regulator approved them. CME would become a mandatory intermediary in a market it currently does not serve.
This is not merely a legal argument. It is a business strategy. CME's share price fell after the CFTC approved Kalshi's perps as investors priced in competition from a market CME had previously locked out via its exchange infrastructure. A successful lawsuit would reverse that.
The "Rushed Review" Complaint
A separate but related argument concerns process, not just substance.
On June 4, 2026, Duffy spoke at the Piper Sandler Global Exchange and FinTech Conference. He described his reaction to the speed of the BTCPERP approval: "They did the review in less than 24 hours, which is a 40.2 self-certification for a novel and complex product, which troubled me. I've had a lot of conversations with the agency, so I'm really disappointed."
Regulation 40.3 — under which the BTCPERP was submitted — is the CFTC's voluntary, full-review process for novel or complex products. It gives the Commission authority to take more time, seek industry comment, and issue a reasoned order before approval. Regulation 40.2, by contrast, is a self-certification process for routine products — the exchange certifies compliance, and the product can list almost immediately.
CME's complaint is that the CFTC granted a 40.3 approval with 40.2 speed, denying competing exchanges and market participants the opportunity to flag legal concerns before the product launched. That procedural argument could form the basis of an Administrative Procedure Act claim independent of the substantive swap-versus-futures debate.
The CFTC order noted that Kalshi submitted the BTCPERP on May 28 and was approved May 29 — a 24-hour turnaround. For a product the CFTC itself described as the "first U.S. listing of a crypto perpetual," that timeline has drawn scrutiny beyond CME.
The CFTC Fires Back
The agency did not take the lawsuit quietly.
Reuters confirmed on June 18 that CME had filed the suit. A CFTC spokesperson responded with pointed language: "Rather than compete in the marketplace, the CME has decided to undertake lawfare against the agency and the Trump Administration's pro-innovation agenda. Incumbents fear the future and having to compete on a level playing field. We look forward to addressing their claims and dismissing this frivolous lawsuit."
That is an unusually aggressive statement for a federal regulator responding to litigation from one of its own registrants. The CFTC clearly views the lawsuit not as a legitimate legal challenge but as incumbency protection dressed in regulatory-compliance clothing.
Chair Selig had already positioned himself on this question before CME announced the suit. Appearing on CNBC's Fast Money earlier in the week, he said: "It's time to approve regulated futures contracts that have no expiration date. We're going to make sure the product's available, but it's well regulated here in the U.S."
What This Means for Prediction Market Traders Right Now
The short answer: Kalshi's perps stay live for now.
Lawsuits against federal agencies move slowly. A preliminary injunction would require CME to show that it faces immediate irreparable harm — difficult to prove when Kalshi's product is generating volume that CME currently does not offer. Without a court order to the contrary, the CFTC approval stands and Kalshi's BTCPERP continues trading.
The CFTC simultaneously issued a no-action letter (CFTC Letter 26-17) confirming that Coinbase Financial Markets could also offer perpetual contracts to U.S. customers through its affiliated foreign board of trade, Deribit FZE. That approval flows directly from the Kalshi BTCPERP precedent. A successful CME lawsuit challenging the legal foundation of the Kalshi order could cloud Coinbase's approval as well.
For users already trading Kalshi's BTCPERP: the product is accessible on Kalshi's platform, regulated, and operating under a valid CFTC order. The legal uncertainty affects the long-term regulatory framework, not your ability to trade today.
For users considering opening an account specifically for perps: this litigation represents real but medium-term legal risk. Monitor the case docket as CME and the CFTC argue the classification question before a federal district court — likely in Washington, D.C. or the Northern District of Illinois.
Why This Matters Beyond Kalshi
The global market for perpetual futures generated an estimated $61.7 trillion in trading volume in 2025, according to Finance Magnates. The offshore market is dominated by a handful of non-U.S. platforms that American retail investors have been accessing in regulatory gray areas for years.
The CFTC's approval of the Kalshi BTCPERP was an explicit policy choice to bring that volume onshore under U.S. regulation — to create a domestic, supervised alternative to offshore crypto perps. Chair Selig has framed it as part of the Trump administration's pro-innovation, pro-digital-asset regulatory agenda.
CME's lawsuit puts that agenda on trial. If CME wins:
- Kalshi and Coinbase face reclassification of their perps as swaps, requiring different registration, trading, and clearing infrastructure
- Any new entrant offering perps would need CME's blessing on benchmark licensing
- The U.S. crypto perps market returns to regulatory limbo — or to CME's own infrastructure if CME decides to list the products itself
If the CFTC wins:
- The perps approval stands, Kalshi and Coinbase continue building market share
- Other DCMs can follow the same 40.3 pathway to list perps
- The CFTC's authority to approve novel derivatives expands
There is also a secondary question about Duffy's timing. He announced the lawsuit on the same day CME disclosed that he will step down as CEO in March 2027, to be succeeded by company insider Lynne Fitzpatrick — who will become CME's first female chief executive. Whether the lawsuit is a legacy play, a genuine legal conviction, or a competitive maneuver on the way out the door, the financial markets will be watching.
FAQ
Is CME suing Kalshi directly? No. CME is suing the CFTC — challenging the agency's decision to approve the BTCPERP as a futures contract. Kalshi is not a named defendant, though the outcome directly determines whether Kalshi's product can continue trading as currently structured.
What is the difference between a futures contract and a swap under Dodd-Frank? Under the Commodity Exchange Act and Dodd-Frank, futures contracts must have a fixed term and converge to a final settlement price. Swaps involve ongoing exchanges of cash flows between two parties and are regulated under a separate framework that requires different registration (swap dealer registration) and clearing through CFTC-approved derivatives clearing organizations. CME argues that perpetual futures — which have no fixed term and involve continuous funding-rate payments between traders — meet the legal definition of a swap, not a future.
Can US users still trade Kalshi's Bitcoin perps? Yes. The CFTC order approving the BTCPERP remains valid while the lawsuit is pending. No court has issued an injunction, and there is no indication the CFTC will voluntarily revoke the order. Kalshi's perps are available to U.S. users on the Kalshi platform.
Does this affect Polymarket? The Kalshi BTCPERP is a prediction market platform's perpetual futures product — distinct from Polymarket's event contract business, which uses a different legal framework (QCX LLC, sports-only for U.S. users). This lawsuit targets Kalshi's crypto derivatives expansion, not the core event-contract business that both Kalshi and Polymarket operate.
What happens next? CME's complaint will be filed in federal district court. The CFTC will respond, likely moving to dismiss. If the case proceeds, both sides will brief the futures-versus-swaps classification question on the merits. An appellate ruling — potentially reaching the Supreme Court given the stakes — could take two to four years.
Sources & Verification
- CFTC approves KalshiEX BTCPERP: CFTC Press Release 9240-26, May 29, 2026
- CFTC Order, full text: Order Approving KalshiEX LLC BTCPERP Futures Contract
- CFTC Policy Statement on Perpetual Contracts: CFTC Press Release 9242-26, May 29, 2026
- CFTC Chair Selig statement on BTCPERP approval: cftc.gov/PressRoom/SpeechesTestimony/seligstatement052926, May 29, 2026
- CME CEO Duffy CNBC announcement, quotes, and Lynne Fitzpatrick succession: CNBC, June 17, 2026
- CME Duffy stepping down press release: CME Group press release, June 17, 2026
- Reuters confirms CME filed June 18; CFTC "frivolous" statement: Reuters, June 17–18, 2026
- Duffy Piper Sandler conference quotes (June 4, 40.3 vs 40.2 review): Markets Media, June 2026
- Coinbase perps approval (CFTC Letter 26-17): CFTC.gov, May 29, 2026
- Kalshi $5.5B two-week perps volume: Bloomberg, June 2026
- Global crypto perps market $61.7T 2025: Finance Magnates, June 2026